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To colonize during disease and prevent consumption by environmental unicellular eukaryotes, bacteria often
disrupt phagocytosis. In this issue, Ma et al. (2009) show that Vibrio cholerae delivers the actin-crosslinking
T6SS effector VgrG-1 following phagocytosis. The effector then causes irreversible cytoskeleton destruction,
leading to bystander protection of the extracellular bacterial population.Vibrio cholerae is an extracellular path-
ogen that causes diarrhea by secretion
of toxins that elicit fluid secretion from
intestinal enterocytes. The ability of
V. cholerae to establish persistent coloni-
zation of the small intestine has been sug-
gested to require evasion of host phago-
cytic cells through the action of the
actin-crosslinking toxin MARTX and other
secreted factors (Olivier et al., 2007). In
this issue, Ma and colleagues (Ma et al.,
2009) present evidence that some strains
of V. choleraemay, in addition, utilize type
VI secretion to prevent phagocytosis.
Type VI secretion systems (T6SS) are
clusters of 12–20 genes found in many
Gram-negative pathogens and include
the secreted proteins Hcp and VgrG, two
highly conserved components of nearly
all known T6SS (Cascales, 2008). The
functional significance of these genes
was initially characterized in V. cholerae,
where secretion of Hcp and VgrG proteins
to supernatant fluids was shown to be
important as a defense against predation
by Dictyostelium discoidium (Pukatzki
et al., 2006). Hcp assembles into hexame-
ric ring structures that may form a regu-
lated pore for secretion of putative effec-
tors out of the bacterium (Mougous et al.,
2007). Expression of Aeromonas hydro-
philaHcpwithin eukaryotic cells is associ-
ated with induction of apoptosis, possibly
related to its pore-forming activity (Suarez
et al., 2008). VgrG proteins, which have
homology to trimeric phage T4 tail spike
proteins, are suggested to assemble into
a trimer that associates with Hcp. It is
proposed that VgrG proteins thus extend
away from the bacterium to contact the
eukaryotic cell membrane and transfer
effectors directly to the target eukaryoticcell cytosol. Some of the many VgrG
proteins are referred to as ‘‘evolved
VgrGs,’’ as they are fusions of VgrG to
enzymes, suggesting that they are effec-
tors directly introduced into the host cell
by the attached VgrG (Pukatzki et al.,
2007).
Study of T6SS has been extremely
active in the past few years, but clear
distinction of T6SS effector molecules
has been hampered by the fact that the
secreted proteins Hcp and VgrG are both
potential effectors as well as necessary
components of the secretion machinery.
The best-characterized ‘‘evolved VgrG’’
is VgrG-1 secreted by V. cholerae. This
VgrG protein has an attached C-terminal
actin-crosslinking domain (ACD) that is
59% identical to the well-characterized
ACD from the V. cholerae MARTX toxin,
also known as RtxA (Sheahan et al.,
2004). The MARTX ACD covalently links
actin by introducing an isopeptide bond
between lysine 50 and glutamate 270 of
different G-actin monomers and sequen-
tially adding monomeric or crosslinked
actin to form long-chain oligomers
(Kudryashov et al., 2008). Actin crosslink-
ing represents a highly efficient mecha-
nism for cell rounding, not only because
the reaction depletes the cellular G-actin
pool, stimulating cytoskeleton depoly-
merization, but also because crosslinked
forms of actin actively disrupt actin poly-
merization by inhibiting further extension
of a growing actin filament (Kudryashov
et al., 2008). Similar to the MARTX ACD,
the ACD of VgrG-1 crosslinks actin when
transiently expressed in HEp-2 and COS-
7 cells (Sheahan et al., 2004), and VgrG-1
protein crosslinks purified actin in vitro
(Pukatzki et al., 2007).Cell Host & MicrobeIn the study by Ma et al. (Ma et al.,
2009), mutant forms of VgrG-1 were
created, in which the ACD was replaced
with either an epitope tag, which allows
monitoring secretion by western blotting,
or with b-lactamase, which facilitates
monitoring of translocation using the
FRET reagent CCF2-AM. It was found
that the modified VgrG-1 can still secrete
Hcp and VgrG-1 to supernatant fluids,
but it no longer functioned to crosslink
actin, induce rounding of macrophages,
or kill Dictyostelium. These results disso-
ciate the structural function of VgrG-1
from its effector function.
Since ACD directly targets monomeric
actin and not filamentous actin, treatment
of cells with actin polymerization inhibi-
tors like cytochalasin D would be
expected to enhance crosslinking by
increasing the pool of G-actin, as was
previously demonstrated for actin cross-
linking by MARTX (Cordero et al., 2006).
By contrast, VgrG-1-mediated actin
crosslinking is completely blocked in
macrophage cell lines treated with cyto-
chalasin D. This led the authors (Ma
et al., 2009) to speculate that VgrG-1 is
not transferred across the eukaryotic
plasma membrane but rather across
a vacuolar membrane after endocytosis,
a process that requires actin polymeriza-
tion. Indeed, 5% of the bacteria are viable
intracellularly for up to 1 hr after phagocy-
tosis. Inhibition of acidification of the
vacuole by bafilomycin A increased
survival by over 200%, suggesting that
the bacteria are normally eliminated by
macrophages, but not before they have
had a chance to deliver the VgrG-1 to
the cytosol to initiate actin crosslinking.
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nonphagocytic cells that are nor-
mally resistant to actin crosslink-
ing by VgrG-1 were shown to be
susceptible after transfection with
the FcgRII to facilitate opsono-
phagocytosis using anti-Vibrio
antibodies.
Thus, bacteria that are engulfed
by a phagocytic cell can success-
fully deactivate the ability of the
cell to initiate a new round of
phagocytosis (Figure 1). In this
way, individual V. cholerae
bacteria execute a martyrdom
attack, delivering an antiphago-
cytic toxin across the vacuolar
membrane after phagocytosis
that then protects the remaining
extracellular bacteria. During
infection, this process would
defend against local phagocytic
cells such as macrophages,
neutrophils, and dendritic cells,
while perhaps simultaneously
inhibiting release of chemokines
and cytokines for recruitment of
reinforcements. In the environ-
ment, bacteria would be protected from
unicellular eukaryotes that survive by
predation on bacteria.
The trigger within the vacuole that
signals V. cholerae to initiate type VI
effector translocation remains to be
determined, as does the broader signifi-
cance of the observation that delivery of
VgrG-1 requires phagocytosis. Other
T6SS, including that of A. hydrophila
(Suarez et al., 2008), are associated with
inhibition of phagocytosis. Thus, it is likely
A. hydrophila and other Gram-negative
bacteria use T6SS similar to V. cholerae,
assuring survival of the entire pop-
ulation by sacrifice of a few
members.
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Figure 1. Type VI Secretion byVibrio choleraeOccurs after
Endocytosis
V. cholerae are taken up intracellularly by actin-dependent endocy-
tosis. After uptake, type VI secretion is initiated, and the bacteria
transfer the effector protein VgrG-1 into the cytosol. The actin-
crosslinking domain of VgrG-1 covalently crosslinks actin, resulting
in inhibition of actin polymerization and thus phagocytosis.
Bacteria that remain extracellular are then resistant to killing by
the deactivated phagocytic cell.
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